PCSS Podcast

Medication-assisted treatment is widely accepted treatment for patients with opioid use disorders. Still, patients have many reasons, spoken and unspoken, to be reluctant to start this potentially life-saving treatment. On this episode, Ashley Braun-Gabelman, PhD, discusses the importance of addressing this resistance and why it's important to explore this barrier to treatment head on. Dr. Braun Gabelman is a clinical psychologist ...

Today we discuss non-opioid pharmacological management of chronic pain with Dr. Kevin Sevarino. Dr. Sevarino received his Doctorate of Medicine in 1982 from McGill University and his Ph.D. in Molecular Biology in 1983 from the University of Connecticut. He is an Assistant Clinical Professor of Psychiatry at Yale University and the University of Connecticut Schools of Medicine. Dr. Sevarino is an activ...

Today we will be talking about the use of naltrexone for the treatment of opioid use disorder therapy. Naltrexone is an opioid blocker, or antagonist, that has limited prevalence of use compared with buprenorphine, a partial agonist, and methadone, a long-acting agonist. Joining us for this conversation is Dr. Adam Bisaga, an academic psychiatrist, educator and clinician.  He is a Professor of Psychia...

Dr. Lynn Webster is one of the world's leading pain experts. He is board certified in anesthesiology, pain medicine and addiction medicine. Among his numerous accomplishments, Dr. Webster is the founder of Lifetree Pain Clinic in Utah, has served as a Past President of the American Academy of Pain Medicine and has published more than 150 scientific peer-reviewed journal articles over the course of his...

As a member of the committee that developed the CDC opioid guidelines and a primary care physician who treats chronic pain patients, Dr. Roger Chou is a uniquely situated authority in the conversation on opioid management. In episode one Dr. Chou talked about the guidelines themselves and, in this episode, he rejoins the podcast to discuss his personal experiences in applying the CDC guidelines in cha...

Opioid use disorder is commonly known to be dangerous. The media has effectively spread the message of the danger and fatal consequences of overdose from misused prescription opioids and illicit drugs such as heroin. What many people, including medical professionals, do not commonly know is that opioid use disorder is the psychiatric condition with the highest mortality. Each year opioid use disorder ...

Buprenorphine is the most frequently used medication to treat opioid use disorder in this country. It is also under-utilized due to the dearth of physicians trained and familiar with how to start it. On this episode Dr. Edwin Salsitz will discuss how to initiate buprenorphine in the office setting, called induction. Dr. Salsitz is an attending physician in the Beth Israel Medical Center, Division of C...

Medication-assisted treatment is an important approach for some people with substance use disorders. It is also frequently misunderstood--isn't treating someone with methadone for a heroin problem simply "trading one addiction for another?" Our guest, Dr. Frances Levin, will discuss this and other misconceptions regarding medication-assisted treatment. 

Dr. Levin ...

Welcome to episode 1 of the American Academy of Addiction Psychiatry podcast hosted by Lysander Jim, MD and Mauro Zappaterra, MD-PhD.

Our first guest is Dr. Roger Chou. As a member of the committee that developed the CDC opioid guidelines released this April, Dr. Chou has a unique perspective on the development, rationale and scientific evidence for the recommenda...